Related Experiment Videos

The development of a Q-sort behavioral rating procedure for pediatric HIV patients

H A Moss1, P Brouwers, P L Wolters

  • 1Pediatric Branch, National Cancer Institute, Bethesda, Maryland.

Insights

Pediatric HIV patients with central nervous system disease show altered social and emotional behaviors. Treatment with AZT may improve these behavioral symptoms in some children.

Area of Science:

  • Neuroscience
  • Pediatric Psychology
  • Infectious Diseases

Background:

  • Pediatric HIV infection can lead to central nervous system (CNS) disease.
  • CNS involvement impacts neurodevelopment and behavior in children.
  • Understanding these behavioral changes is crucial for effective patient management.

Purpose of the Study:

  • To develop and validate a Q-sort procedure for assessing behavioral changes in pediatric HIV patients with CNS disease.
  • To identify specific social, emotional, and motivational behavioral patterns associated with HIV-associated encephalopathy.
  • To evaluate the impact of antiretroviral therapy on these behaviors.

Main Methods:

  • A Q-sort procedure was developed to assess behavior in 180 HIV-infected pediatric patients.
  • Factor analysis was used to derive behavioral scales from the Q-sort ratings.
  • Behavioral data were compared between patients with and without HIV-associated encephalopathy across different age groups.

Main Results:

  • Younger encephalopathic patients exhibited more apathy and less social behavior than non-encephalopathic peers.
  • Older encephalopathic patients showed higher scores for depression, autism, and irritability.
  • A subgroup of 26 patients demonstrated significant improvement in these elevated scores after 6 months of AZT treatment.

Conclusions:

  • HIV-associated encephalopathy significantly alters social, emotional, and motivational behaviors in pediatric patients.
  • Behavioral deficits are age-dependent, with distinct patterns observed in younger and older children.
  • AZT treatment shows potential for mitigating some of the negative behavioral consequences of HIV-CNS disease.

Related Concept Videos